Since 1993, the infection consultation service for bacteraemia has seen 310 patients in the Medical and Surgical Directorates at Ninewells Hospital and Kings Cross Hospital. A random sample of 100 was audited. Case-notes were incomplete for five patients, leaving 95 fully-audited patients. Clinical outcome measures were death from infection, and readmission within 2 weeks of discharge. Initial treatment was inconsistent with antibiotic policy in 46 patients (48%). Antibiotic treatment was changed in 37 (80%) of these patients: increased in intensity in 19 (41%) and decreased in 18 (39%). Changes were also made in 30 (61%) of the 49 patients whose initial treatment was consistent with sepsis policy-increased in seven (14%) and decreased in 23 (47%). Median daily antibiotic costs were lowered in patients whose initial treatment was consistent with sepsis policy (£10.10 vs. £7.28, p = 0.0274). However, in the other patients, savings were balanced by increases {p -0.7696). Consultation required one consultant session per week (3.5 h) and the audit required an additional 16 consultant sessions. Seven patients died, but only one death was directly related to infection. Six patients were readmitted to hospital within 2 weeks, in three due to recurrence of infection. Changes to treatment were recommended in the majority of patients, regardless of whether initial treatment complied with the sepsis policy. The service primarily redistributed resources rather than reducing costs. A fully audited service requires considerable consultant time, but we believe such time is well spent.
Introduction
Bacteraemia continues to be prevalent in the community and all hospital departments. 1 It is a common serious illness with reported mortality of 20-40%, 1 " 3 which is strongly correlated with the severity of underlying disease. 4 Death is two to three times more likely to occur in those treated with inappropriate antibiotics. 1 ' 2 Therefore, early recognition of the clinical features of sepsis, rapid detection of the causative organism and prompt initiation of appropriate antibiotics are all essential aspects of management. Unfortunately, the clinical signs and symptoms of sepsis or bacteraemia 5 are not always easy to recognize and often the burden of initial recognition and subsequent management fall on those junior staff who have the least knowledge and experience, leading to prescription of inappropriate antimicrobials (type, route or dose) and/or delay in prescribing antimicrobials. 6 The potential consequences of inappropriate treatment include excessive drug costs, increased patient morbidity and mortality, prolonged hospital stay and selection of resistant organisms. 7 "
A prospective audit of costs and outcomes of aminoglycoside treatment and of therapy of Cramnegative bacteraemia performed in our hospital between August 1990 and January 1991 revealed clear evidence of undertreatment (underdosing of aminoglycosides) in patient with high risk of serious sepsis (including patients in the intensive care unit) and overtreatment of patients with low risk of infection. 12 Both of these problems required correction and further measurement to complete the audit cycle. In our hospital, the management of bacteraemia and sepsis within general medical and surgical wards has traditionally been based on the use of a hospital antibiotic formulary, telephone-based consultation by medical microbiologists, and infrequent solicited requests for infectious diseases consultation. These requests were usually late in the course of the illness when complications had arisen because of failure of response to initial antibiotic therapy. Based on evidence from the previous audit 12 we initiated a number of changes to correct the problems which had been identified, including publication and dissemination of treatment guidelines for suspected sepsis, and consultant review of patients with bacteraemia in the Directorates of Medicine and Surgery. These Directorates do not include the Intensive Care and Medical High Dependency Units which already receive daily visits by consultants in Medical Microbiology.
Methods

Implementation of sepsis protocol and Infection Consultation Service
The directorate of medicine of the Dundee Teaching Hospital NHS Trust (DTHT) agreed in early 1993 to introduce a locally-developed sepsis management protocol and an infection consultation service modelled on that previously described at Northwick Park Hospital in London. 13 However, there were a number of important differences between the operation of our service and that of Northwick Park. In our model it was agreed that the infectious disease (ID) clinicians would give the final clinical opinion after seeking the advice of the microbiologists, and that they would only have unsolicited access to patients with bacteraemia, as opposed to other patients with unconfirmed infection or positive microbiology at other sites. The bedside consultation was always by an ID consultant as opposed to a junior member of the team, as was often the case at Northwick Park. The clinical benefits of this type of collaborative unsolicited consultation have been clearly described in the Northwick Park model. 14 However, we wished to examine the impact of our consultation service and treatment protocol not only on clinical outcome but on the appropriateness and cost of antibiotic treatment, so as to complete the audit cycle.
Implementation Strategy
From April 1993, clinicians within the medical directorate (total of 364 in-patient beds on 11 wards on two sites) have allowed the ID clinicians unsolicited access to see patients with a documented bacteraemia. The clinician then advises on appropriate management. The medical directorate was initially targeted because it accounted for approximately half of the trust's antibiotic-prescribing budget. This service was adopted a year later by the directorate of surgery (144 beds on six wards on one site). Before these services were adopted, a short discussion paper had been presented to both directorates for approval, which highlighted and promoted the various benefits of the service to the patients as well as the directorates. A sepsis protocol to be used by junior doctors in the empirical management of sepsis was established after consultation with a multidisciplinary group which included clinicians who would use the service, in addition to clinical pharmacists, medical microbiologists and infectious disease specialists. The protocol was produced on a single sheet and was available in poster form on all the relevant wards (see Figure 1 ). It was aimed at relatively inexperienced doctors and gave advice on best-guess therapy pending the results of culture and other investigation.
Data collection
Following each consultation, the ID consultant would prospectively complete a brief questionnaire which documented information on patient demographics, presence of co-existing co-morbid illness, the type, site and severity of infection, attending teams' working diagnosis and management, the ID consultants' diagnosis and suggestion for changes in management. Following discharge, the case notes of a randomly selected sample were reviewed by DN to complete recording data on the total duration of oral and intravenous antibiotic therapy and the ultimate outcome of the episode of sepsis.
Definitions
The primary clinical outcomes of interest were death, and readmission due to infection within 2 weeks of hospital discharge. This interval was based on the results of the previous audit, in which follow-up was continued for 3 months but the majority of readmissions due to recurrence of infection occurred within 2 weeks. 
Contaminant
A bacteraemia was termed as a contaminant if there was no clinical evidence of sepsis. Sepsis was defined as the presence of at least two of the following: fever < 3 6°C or > 3 8°C ; heart rate >90/min; respiratory rate >20/min; WBC < 4 or > 1 2 . This has been suggested as a useful clinical model of predicting significant bacteraemia. 5 Antibiotics were discontinued if criteria for contaminant microorganisms were fulfilled.
Inappropriate antibiotic
Antibiotics were judged to be inappropriate by three categories: drug, dose or route.
Costs of treatment
Drug costs means the cost of antimicrobial agents alone and does not include the cost of preparation or administration of i.v. drugs. We calculated the basic drug cost of each antibiotic already prescribed at the time of first consultation and the cost of the antibiotic regimen following ID consult. All costs were calculated as the daily cost of the prescribed daily dose using prices quoted in the British National Formulary of February 1995.
Data analysis and statistics
Data were analysed with Excel 5.0 and Minitab 10.0. The distribution of drug costs was highly skewed, and the impact of the consultant service was analysed with both mean and median antibiotic costs. The analysis was based on changes in mean and median daily drug cost. These were calculated by subtracting the cost of one day of treatment after the ID consultation from the cost of treatment on the day before consultation. The mean and median daily drug costs were then calculated for the entire study sample. Differences between population medians and their 95% confidence intervals were estimated from the Mann-Whitney test in Minitab 10.0. The 95% CIs indicate that the median of a second sample from the same population is 95% likely to lie between these extremes. The median is the cost incurred by at least 50% of the sample, therefore the median is a reasonable estimate of the cost that is likely to be incurred by an individual patient. The mean is influenced by outlying patients with unusually high costs, therefore the mean is a better guide to total cost over a period of time. From the perspective of a budget holder, the mean is an appropriate measure of central tendency, because budget holders need to take outliers into account in their calculations. However, the median is a more appropriate measure of central tendency for statistical analysis of differences in cost. 23 The statistical analysis was based on a point estimate of the difference in median antibiotic costs before and after consultation. This is an estimate of the difference in population medians, and is not the same as the difference in the sample medians.
Results
Between April 1 1993 and March 1995, 310 episodes of bacteraemia were detected, with more than 75% originating from the Medical Directorate because the service only began operating in the Surgery Directorate in 1994. The sample of 95 case records (study group) which were fully audited reflects roughly a third of the bacteraemia seen during the 24-month study period.
Study group
The study population consisted of 43 men and 52 women. The mean age was 67.8 years. A hospitalacquired (nosocomial) infection was defined as an episode of bacteraemia detected more than 48 h after hospital admission: 72% of the bacteraemias in our study were community-acquired. The most common primary disease leading to bacteraemia was pneumonia (17%) followed by urinary tract infection (14%), cholecystitis/cholangitis (14%) and bacteraemia of unclear aetiology (11.5%) ( Table 1 ). There were 109 episodes of bacteraemia. Escherichia coli was the most commonly isolated organism, followed by Staphylococcus aureus and Streptococcus pneumoniae ( Table 2) .
Each patient with significant bacteraemia was seen twice on average. This amounts to an average of 4.9 consultations per week (approximately one clinical session) with the first consultation on the same day as notification of the positive blood culture. One third of patients had significant underlying co-morbid illness (liver disease, cardiovascular disease, respiratory disease or immunosuppression) prior to hospital admission.
In 95/100 patients, we had sufficient data to be able to analyse the impact of the infection consultation service on antibiotic prescribing and compliance with the sepsis protocol. Advice given following consultation was related to diagnosis in 30/95 (31%), treatment 67/95 (70%), investigation 28/95 (30%), isolation 1/95 or transfer of patient 6/95 (6%). In nine patients, a surgical opinion was recommended. Advice was followed in 9 1 % of cases. At the time of consultation the correct diagnosis had already been made in 45/95 (47%) of patients and considered in 20/95 (21 %) of patients. In 30/95 (31 %) of patients an incorrect diagnosis had been made. In 6/95 (6%) patients an incorrect diagnosis was made by the ID consultant. 30%  16%  12%  6%  6%  4%  4%  3%  3%  2%  2%  2%  2%  1%  1%  1%  1%  1%  1%  1%  1% MSA, meth ici 11 i n-sensiti ve Staphlococcus aureus; CNS, coagulase-negative staphylococci.
Impact of consultation on antibiotic prescribing
At the time of consultation, 46 (48%) of patients were not receiving antibiotic treatment which was consistent with the sepsis protocol; indeed, 12 patients were not receiving any antibiotic treatment at all despite signs of sepsis (Table 3) . A change in treatment was recommended and made for 37 (80%) of these patients; in just over half (19/37; 51%) the recommended change was an increase in treatment intensity (Table 3) . Treatment was not changed in nine cases, despite the fact that it was not consistent with the policy. In two cases the reason was that the advice of the ID consultant was not followed; both patients were receiving third-generation cephalosporins which were not indicated on clinical or microbiological grounds. In the remaining seven cases, no change was recommended because, although the treatment was not strictly according to the policy, the regimen was similar in safety, efficacy and cost to that recommended by the policy (e.g. cefuroxime plus metronidazole instead of co-amoxyclav for biliary sepsis).
Antibiotic treatment consistent with the sepsis protocol was started before the ID consultation in 49 cases. Changes were recommended in a lower proportion of these patients (30/49; 61%) and in the majority (23/30; 77%) treatment intensity was decreased. The recommended increases in treatment intensity were addition of ceftazidime because of isolation of Pseudomonas aeruginosa or Stenotrophomonas maltophilia (2 patients), change from co-amoxyclav to high-dose flucloxacillin for treatment of serious sepsis in association with Staph. aureus bacteraemia (2 patients), addition of benzyl penicillin for suspected endocarditis (1 patient), addition of gentamicin to co-amoxyclav for biliary sepsis (1 patient) and increase in dose for treatment of meningitis (1 patient). Treatment was stopped in four patients despite the fact that it was consistent with the policy recommendations for the attending physician's diagnosis. In all four cases the ID consultant disagreed with the diagnosis of sepsis, and the blood culture isolate was regarded as a contaminant; none of these patients had signs of recurrent infection.
Median values were used for statistical analysis of the difference in antibiotic costs before and after ID consultation (see Statistical analysis in Methods). Because of the skewed distribution of the cost data, the change in median daily cost of antibiotics (Table 4) is lower than the change in mean daily cost shown in Table 3 . Nonetheless, the changes made after ID consultation significantly reduced the median daily cost of antibiotics in the patients whose initial treatment was consistent with the sepsis policy (Table 4 ). However, in the patients whose initial The difference is the cost before consultation minus the cost after consultation; a positive difference indicates a reduction in costs following consultation. The point estimate of the difference in population medians is not the same as the difference between the sample medians (see Statistical Methods).
treatment was not consistent with the policy, savings in some patients were almost exactly balanced by increased treatment costs in others, which includes 12 patients whose treatment was initiated by the ID consultant. The overall effect of ID consultation was a small reduction in median daily costs by £2.19 (95% Cl from £0.13 increase to £5.77 decrease; Table 4 ). Because of the skewed distribution of costs, the impact on mean antibiotic costs was somewhat greater: mean reduction £2.40 (95% Cl from £2.60 increase to £7.80 decrease).
sepsis following cancer chemotherapy, and one patient had a further episode of bacteraemia originating from the urinary tract. In all of these cases the problem was thought to be due to re-infection rather than recurrence of the original infection. Therefore, a total of 13 patients either died or were readmitted within 2 weeks but infection was implicated in only four cases and in only one of these was there clear evidence that complications were due to infection rather than underlying disease.
Staff resources
The investment of consultant time required to operate the service was about one consultant session per week, equivalent to approximately £5000 per year.
Furthermore, for such a service to be effective in the long term, it is critical that its impact is evaluated by a process of continuous audit and educational feedback. The audit and feedback required an additional 16 consultant sessions (cost £1450) as follows: data collection, review of case records and completion of questionnaire at 20 min per case record, approximating to 33 h to review 100 case record, equivalent to nine consultant sessions; data entry and analysis, 16 h equivalent to four consultant sessions; data presentation, 12 h equivalent to three consultant sessions. The total cost of running the service, including a full audit and feedback of results, was therefore about £6500 per year. This cost was partially offset by reduced antibiotic costs. However, assuming 200 patients seen per year, the average reduction in antibiotic costs would have to be >£32.50 per patient seen. It is difficult to estimate the overall impact of consultation on antibiotic costs, because it is unclear how long the patient would have continued to receive the initial treatment if the ID consultant had not intervened. However, given a maximum likely reduction in median daily antibiotic cost of £5.77 it is unlikely that total savings would amount to >£32.50 per patient seen.
Clinical outcome
Seven patients died during the first episode of hospitalization. One patient died of fulminant pneumococcal pneumonia and multi-organ failure after being reviewed by the ID team. Six other patients died of underlying disease (cancer, pulmonary embolism, severe heart failure and upper gastrointestinal haemorrhage) rather than sepsis. Six patients were readmitted to hospital within 2 weeks of discharge, and three subsequently died due to a noninfective illness. The other three patients were readmitted due to infection. One patient had sepsis complicating a central i.v. line, one patient had
Discussion
The infection consultation service as currently operated requires one consultant clinical session per week to review all patients in the Directorate of Medicine and Surgery. Just over half of the patients seen were receiving empirical treatment as recommended by the sepsis protocol. Nonetheless, the infection consultation team recommended a change in one or more aspects of treatment in 67 patients. Despite the fact that antibiotic treatment was started by the consultation team in 12 patients, any increase in daily treatment costs for these patients was offset by savings in other patients. Treatment was successful in 91 (96%) of 95 patients. However, this outcome cannot be meaningfully compared with outcome from the previous audit which had a different casemix of patients because it covered all wards in the Trust, including Intensive Care and High Dependency units. The results from our audit were distributed to both clinical directors, and have also been presented to the Directorate of Medicine Grand Meeting as well as to the Trust Quality Group. We conclude that several indicators suggest that ID consultation results in earlier initiation of appropriate antibiotic treatment which is associated with excellent outcome at minimum overall resource cost other than the time of the infectious disease consultants. Hospital antibiotic formularies alone remain an inadequate strategy for improving antibiotic usage and managing sepsis in hospital. 10 For example, in the Northwick Park study, despite a hospital antibiotic policy, over 40% of infected patients were being treated inadequately. 14 A number of studies have reported the importance and benefits of a therapeutic consultation service in managing sepsis 14 or other conditions requiring drug therapies. 15 It should also be remembered that a hospital antibiotic policy can only be a guidance towards appropriate empirical antibiotic treatment which is aimed principally at ensuring effective treatment by inexperienced staff. The present audit shows how much scope there is for reducing the intensity of treatment after review of the patient by an experienced clinician, including stopping antibiotics altogether if the diagnosis of sepsis is questioned. These results are essentially similar to previous reports from other settings, such as neonatal ICU. 16 Despite the attendant benefits of a collaborative service between microbiology and infectious diseases, most hospitals in the UK lack such joint services for managing infections.
The reasons for this are many, and include difficulty in obtaining permission to visit any patient in the hospital on an unsolicited basis, or in finding the staff to provide comprehensive cover. For example, most District General Hospitals do not have infectious disease clinicians, the majority of whom are based in larger regional units, often in teaching hospitals, thereby making provision of such a combined service difficult. Furthermore, the pressures on laboratory services make it difficult for many medical microbiologists to provide such therapeutic consultation. Despite these difficulties, the clinical and economic 17 importance of infection has been recognized by all purchaser units in the UK, as they now demand evidence of hospital infection rates from all trust hospitals as a criteria for judging quality of care. In addition, we believe that purchasers and providers should equally recognize the importance of effective, early management of sepsis, particularly with reference to antibiotic prescribing. Our experience in Dundee has shown that combining a simple sepsis protocol with a clinical infection consultation service, implemented in a pro-active fashion with regular feedback and personal intervention, is an effective means of rationalizing the management of sepsis. The service produced modest savings in overall antibiotic costs but, much more importantly, these were achieved despite appropriate increases in treatment intensity in some patients. The function of economics is to 'improve the distribution of scarce, productive resources which could have alternative uses' not to save money. 18 The description of antibiotics as scarce productive resources is particularly appropriate given the global rise in antibiotic resistance and antibiotic induced secondary infections, such as Clostridium difficile colitis. 19 Control of antibiotic prescribing alone will not control drug resistance, because person-to-person spread of resistant strains occurs independently of antibiotic prescribing. 20 ' 21 Nonetheless, control of antibiotic prescribing is a vital component of a hospital's infection control strategy. 19 It is important to recognize that both undertreatment and overtreatment contribute to selection of antibiotic-resistant bacteria. Unnecessary treatment exposes the normal human flora to the harmful effects of antibiotic treatment with no clinical gain. However, underdosing of patients with established infection may select drugresistant sub-populations from the bacterial pathogen causing the infection. 22 The obvious resource implications of audit have been highlighted and need to be addressed. It is important that this type of continuous audit activity is recognized and resourced. One suggestion would be setting up a formal audit clinic which would be part of the contractual work of the infection consultant. This would be a fixed commitment during which a given number of case records of patients with bacteraemia could be audited and analysed. This system would ensure continued monitoring of the impact of the various infection management measures. Moreover, for this to occur throughout UK hospitals, there needs to be expansion of the number of infection specialists in all hospitals. These may be infectious disease physicians, clinical medical microbiologists, or a new type of infection specialists trained in both internal medicine and medical microbiology. Another alternative is to link medical microbiology to another clinically aligned speciality with an interest in infection such as chest medicine or genito-urinary medicine, thereby maintaining the successful dual approach. Overall, we recommend that other hospitals consider developing such collaborative ventures. Finally, it is vital that senior hospital managers understand their responsibilities with regard to control of antimicrobial prescribing. 19 The emphasis must be on improving the quality of prescribing rather than simply on reducing prescribing costs.
